Skip to content

Clinical trials

Prostatic Neoplasms trials in the United Kingdom with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Neoplasms Phase: Not applicable Country / region: United Kingdom Clear all

79 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20032
20061
20071
20082
20092
20102
20113
20123
20133
20145
20154
20168
20175
20185
20196
20215
20226
20231
20244
20255
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed30
Unknown status20
Recruiting11
Active, not recruiting8
Withdrawn3
Not yet recruiting3
Terminated3
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Royal Marsden NHS Foundation Trust9
University College, London8
Imperial College London5
Guy's and St Thomas' NHS Foundation Trust4
Quadram Institute Bioscience4
The Christie NHS Foundation Trust3
University College London Hospitals3
Wirral University Teaching Hospital NHS Trust3
Cambridge University Hospitals NHS Foundation Trust2
Hull University Teaching Hospitals NHS Trust2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Neoplasms79
Neoplasms6
Disease4
Neoplasm Metastasis4
Adenocarcinoma3
Osteoporosis3
Urinary Bladder Neoplasms3
Colorectal Neoplasms2
Endometrial Neoplasms2
Radiation Injuries2

Trials

Showing 1 to 25 of 79. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.